Virus‐like particles displaying recombinant Der p 1 zymogen to optimize IgG blocking antibody response-Reference-Cited by-同舟云学术

Virus‐like particles displaying recombinant Der p 1 zymogen to optimize IgG blocking antibody response

Published:2021-10-15 Issue:2 Volume:77 Page:664-667
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Jitthamstaporn Sirikarn¹,Sander Adam F.²,Jacquet Alain¹^ORCID

Affiliation:

1. Center of Excellence in Vaccine Research and Development Faculty of Medicine Chulalongkorn University Bangkok Thailand

2. Centre for Medical Parasitology Department of Immunology and Microbiology Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.15129

Reference7 articles.

1. Bacterial superglue enables easy development of efficient virus-like particle based vaccines

2. The Crystal Structure of Recombinant proDer p 1, a Major House Dust Mite Proteolytic Allergen

3. Early Transcriptional Signature in Dendritic Cells and the Induction of Protective T Cell Responses Upon Immunization With VLPs Containing TLR Ligands—A Role for CCL2

4. Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement

5. ClinicalTrials.gov Identifier NCT04839146 Adaptvac Press Release Aug 9th2021 (https://www.adaptvac.com/news).

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mannan‑, VLP-, and flagellin-based adjuvants for allergen-specific immunotherapy: a review of the current literature;Allergo Journal International;2024-07-18